Salacia Kotalanol.
Salacia Kotalanol supplementation for targeted health support. Slows the final step of carbohydrate digestion at the gut wall, so glucose from a starchy meal arrives more gradually instead of in one early peak.
Reviewed March 2026
- Category
- Metabolic
What Salacia Kotalanol is, and what it does.
- Does it work
- Potent blood sugar management compound with Ayurvedic and scientific backing. The isolated compound ensures consistent potency. Useful for carb management. GI side effects are the main limitation.
- How much to take
- Doses vary by extract type. Whole Salacia extracts: 240-500mg before meals.
- Time to feel it
- It acts on the meal you take it with, so a post-meal glucose reading changes the same day. Gas or bloating can arrive just as fast.
- The first dose
- May notice GI effects. Blood sugar effects are measurable.
- With regular use
- Improved blood sugar control with carb-containing meals.
- How well tolerated
- Well tolerated but causes GI effects.
- How it feels
- GI effects possible. Blood sugar benefits measured, not felt.
- The overlooked benefit
- The thiosugar mimics the transition state of sugar splitting, which is why it binds the enzyme far more tightly than the sugar it competes with.
100 to 240mg a day is where Salacia Kotalanol works.
Source: Yoshikawa et al., Chem Pharm Bull, 2002; alpha-glucosidase inhibition studies
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
- Inhibits alpha-glucosidaseEnzyme studies
- Reduces post-meal glucoseClinical trials
- Traditional Ayurvedic useHistorical texts
- Well tolerated in supplementationTrial safety data
Questions people ask about Salacia Kotalanol.
- Is this better than whole Salacia?
- More standardized. Whole Salacia extracts contain kotalanol plus other compounds (salacinol). Isolated kotalanol provides known potency. Both work for blood sugar.
- How does it compare to acarbose?
- Similar mechanism, comparable potency. Acarbose is a prescription drug. Kotalanol/Salacia is available as supplement. Both cause GI side effects.
- Will it cause digestive problems?
- Likely yes, especially initially. The undigested carbs ferment in your colon causing gas and bloating. Effects usually diminish with continued use.
- When should I take it?
- Before carb-containing meals. It needs to be present when carbohydrates arrive for digestion. Taking after meals is less effective.
- What's the difference between kotalanol and salacinol?
- Both are active compounds in Salacia. Kotalanol may be more potent. Whole Salacia extracts contain both. The specific compound matters less than overall efficacy.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Kotalanol and deoxynojirimycin are both sugar-mimicking inhibitors of intestinal alpha-glucosidase, the enzyme that releases glucose from disaccharides. Combining them presses harder on the same step, and the same is true for the digestive side effects.
Supplemental amylase speeds the breakdown of starch into maltose and oligosaccharides, exactly the flow an alpha-glucosidase inhibitor is added to slow at the next step. Placing them in the same meal works against the intended effect.
Blocking alpha-glucosidase leaves more carbohydrate undigested in the small intestine, and a fermentable prebiotic adds to that colonic load. Gas and bloating rise in an additive way.
Kotalanol slows glucose release at the intestinal brush border while berberine acts on AMPK signalling and cellular glucose handling. The two act at different points of the same postprandial sequence.
A viscous soluble fibre slows gastric emptying and the diffusion of sugars to the brush border, while kotalanol blocks the enzymatic release of glucose there. The mechanisms are separate and their effects on one meal add up.
Kotalanol and salacinol are competitive inhibitors of intestinal alpha-glucosidases, slowing the breakdown of disaccharides into absorbable glucose. A broad digestive enzyme blend supplies amylase and glucosidase activity that pushes the same reaction forward. Taken in the same meal the two work against each other, which is worth stating plainly on any formula sheet that carries both.
Psyllium forms a gel that slows gastric emptying and diffusion of sugars to the brush border, while kotalanol slows the enzymatic step at that border. The two act at different points on the same journey, so their effects on post-meal glucose rise may be additive. Both also increase the carbohydrate reaching the colon, which means more fermentation and, for some people, more gas.
Guar gum raises the viscosity of chyme, which slows how fast disaccharides reach the enzymes kotalanol is inhibiting. Two independent brakes on the same process may add. The shared consequence is more unabsorbed carbohydrate reaching the colon, so combined doses are usually built up gradually.
Oat beta-glucan slows carbohydrate delivery through viscosity, a mechanism separate from enzyme inhibition. Combined with an alpha-glucosidase inhibitor, the post-meal glucose curve may be flattened by two distinct routes. The pairing has not been tested as a combination, so the additive reasoning comes from each mechanism being established on its own.
Pectin gels in the stomach and slows emptying, which lengthens the window over which sugars arrive at the brush border. That complements enzymatic slowing rather than duplicating it. No study has combined pectin with a Salacia extract.
Tea catechins inhibit both alpha-amylase and alpha-glucosidase in enzyme assays, hitting the same digestive step from a different chemical direction than the thiosugar sulfonium inhibitors in Salacia. Two inhibitors of the same enzyme family do not necessarily add linearly, since they compete for the same binding sites. In vitro enzyme inhibition is a laboratory measure, not a human glucose outcome.
Chromium acts on the cellular side of glucose handling and insulin signalling, while kotalanol stays in the gut lumen and is minimally absorbed. The two sites are separate, which is the usual argument for combining them. No trial has measured the pair together.
Cinnamon polyphenols have been studied for effects on post-meal glucose response through insulin-signalling and gastric-emptying routes, which do not overlap with brush-border enzyme inhibition. That non-overlap is why the two appear in the same formulas. The combination itself has not been trialled.
Gymnema and Salacia species appear together in Ayurvedic preparations aimed at sugar handling, and both are still combined in modern products on that lineage. Gymnemic acids act on sweet-taste receptors and intestinal glucose transport rather than on glucosidase enzymes. The pairing is documented use plus non-overlapping mechanism, not a measured combination.
Bitter melon's charantin and related constituents have been studied for effects on cellular glucose uptake, downstream of where kotalanol acts. Combining a luminal enzyme brake with a cellular-uptake agent is the usual rationale. Human combination data is absent.
Alpha-lipoic acid is studied for effects on cellular glucose uptake and redox handling, systemic territory that kotalanol does not reach in any meaningful amount. They occupy different ends of the same physiology, which is why formulas pair them. Nothing measures the combination.
Inositol isomers feed second-messenger pathways downstream of the insulin receptor, whereas kotalanol works in the gut lumen. The two do not compete for anything. This is formulation logic without combination data.
Slowing brush-border hydrolysis means more disaccharide and oligosaccharide arrive in the colon, where the resident bacteria ferment it to short-chain fatty acids and gas. The composition of that community shapes how much gas and discomfort a person notices. Whether a specific strain changes the tolerability picture has not been measured.
Resistant starch already delivers carbohydrate to the colon by design, and glucosidase inhibition adds more on top. The combined fermentable load is the thing to watch, since gas and bloating scale with it. Nothing quantifies the pair.
Inulin is fermented in the colon rather than digested, so it stacks with the extra carbohydrate that glucosidase inhibition sends downstream. For someone sensitive to fermentation the combination may be felt sooner than either alone. This is substrate arithmetic, not a tested interaction.
Nothing specific on file for Salacia Kotalanol. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Salacia Kotalanol actually does.
Kotalanol and its relative salacinol are thiosugar sulfonium sulfates: a sulfonium ion paired with an internal sulfate counterion, a structure that mimics the oxocarbenium transition state of glycoside hydrolysis, which is why they bind alpha-glucosidase active sites tightly.
Inhibition of brush-border alpha-glucosidases, maltase, sucrase and isomaltase, slows the final step that turns disaccharides into absorbable glucose, spreading absorption over a longer window rather than blocking it.
The compounds act inside the intestinal lumen at the enzyme surface and are minimally absorbed themselves, so their action is local rather than systemic; this is why the class carries digestive rather than systemic considerations.
Carbohydrate that escapes hydrolysis reaches the colon and is fermented by resident bacteria into short-chain fatty acids and gas, which is the mechanistic origin of the flatulence and bloating reported across the whole alpha-glucosidase inhibitor class.
Where Salacia Kotalanol comes from.
It comes from the root and bark of a climbing plant used in Ayurveda. The material is simmered in water, the same way it was traditionally prepared, because the active compounds dissolve readily. Some makers then concentrate that extract further and test each batch so the label figure holds.
Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.
Root and stem bark of Salacia reticulata or Salacia oblonga; the thiosugar content differs by species, plant part and growing region
Milled bark and root are extracted with water, the same route as the traditional decoction, because the sulfonium sulfates are highly water-soluble
Optional resin or membrane steps concentrate the thiosugar fraction and reduce mangiferin and tannin content
Batches are assayed and adjusted to a stated thiosugar percentage, since native content is not consistent between lots
Spray-dried extract is encapsulated or blended into meal-time formulas
The forms it comes in.
The essence, in one line each.
- In mice given oral Salacia reticulata extract, the authors report changes in lung immune measures after a respiratory viral challenge and propose a gut-microbiota route for it; an animal mechanism study of the whole extract, not of kotalanol, and not human evidence.Animal study. Romero-Pérez GA et al., 2016 (Frontiers in Immunology). PMID 27066007 ↗
These are the studies our verdict leans on, chosen from the 1 we read for Salacia Kotalanol. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.